{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["17(4)"],"submitter":["Koh J"],"pubmed_abstract":["<h4>Background</h4>Impulse control disorders are detrimental neuropsychiatric symptoms of Parkinson's disease. Increased impulsivity is a predisposing factor for impulse control disorders and should therefore be controlled. Recently, mindfulness meditation as a non-drug therapy has been reported to be useful in improving neuropsychiatric symptoms, such as impulsivity.<h4>Methods</h4>We performed a prospective single-arm, open-label pilot trial to investigate the effectiveness of mindfulness meditation to control impulsivity in patients with Parkinson's disease (UMIN clinical trials registry: UMIN000037779).<h4>Results</h4>Twenty patients with Parkinson's disease were enrolled in an 8-week mindfulness meditation program. As a primary outcome, we investigated whether the score of the Barratt"],"journal":["PloS one"],"pagination":["e0266354"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8985985"],"repository":["biostudies-literature"],"pubmed_title":["A single-arm open-label pilot study of brief mindfulness meditation to control impulsivity in Parkinson's disease."],"pmcid":["PMC8985985"],"pubmed_authors":["Ohmae Y","Taruya J","Yasui M","Ito H","Koh J","Takahashi M","Terada M","Sakata M"],"additional_accession":[]},"is_claimable":false,"name":"A single-arm open-label pilot study of brief mindfulness meditation to control impulsivity in Parkinson's disease.","description":"<h4>Background</h4>Impulse control disorders are detrimental neuropsychiatric symptoms of Parkinson's disease. Increased impulsivity is a predisposing factor for impulse control disorders and should therefore be controlled. Recently, mindfulness meditation as a non-drug therapy has been reported to be useful in improving neuropsychiatric symptoms, such as impulsivity.<h4>Methods</h4>We performed a prospective single-arm, open-label pilot trial to investigate the effectiveness of mindfulness meditation to control impulsivity in patients with Parkinson's disease (UMIN clinical trials registry: UMIN000037779).<h4>Results</h4>Twenty patients with Parkinson's disease were enrolled in an 8-week mindfulness meditation program. As a primary outcome, we investigated whether the score of the Barratt","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-05T13:24:06.614Z","creation":"2025-04-05T13:24:06.614Z"},"accession":"S-EPMC8985985","cross_references":{"pubmed":["35385563"],"doi":["10.1371/journal.pone.0266354"]}}